L-亮氨酸-2-D1

• 常用名: L-亮氨酸-2-D1
• 英文名: l-leucine-2-d1
• CAS号: 89836-93-1
• 分子量: 132.17900
• 密度: N/A
• 沸点: N/A
• 分子式: C₆H₁₂DNO₂
• 熔点: >300 °C(lit.)
• 闪点: N/A

L-亮氨酸-2-D1用途

L-亮氨酸-d1是氘标记的L-亮氨酸。L-亮氨酸是一种必需的支链氨基酸(BCAA),可激活mTOR信号通路[1]。

L-亮氨酸-2-D1名称

本表展示该化学物质的中文名称、英文系统名、各类中文与英文别名信息。

• 中文名: L-亮氨酸-2-D1
• 英文名: l-leucine-2-d1

L-亮氨酸-2-D1生物活性

本表记录该化合物相关生物活性、作用靶点、活性说明与生物实验相关数据。

• 描述: L-亮氨酸-d1是氘标记的L-亮氨酸。L-亮氨酸是一种必需的支链氨基酸(BCAA),可激活mTOR信号通路[1]。
• 相关类别:
  信号通路 >> PI3K/Akt/mTOR 信号通路 >> mTOR
  研究领域 >> 代谢疾病
• 体外研究: 氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
• 参考文献:

  [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

  [2]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [3]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [4]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [5]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [6]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [7]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [8]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [9]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [10]. Rachdi L, et al. L-leucine alters pancreatic β-cell differentiation and function via the mTor signaling pathway. Diabetes. 2012 Feb;61(2):409-17.

  [11]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [12]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [13]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [14]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [15]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [16]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [17]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [18]. Baoshan Xu, et al. Stimulation of mTORC1 with L-leucine rescues defects associated with Roberts syndrome. PLoS Genet. 2013;9(10):e1003857.

  [19]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [20]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [21]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [22]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [23]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [24]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

  [25]. Bruckbauer A, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond). 2012 Aug 22;9(1):77.

L-亮氨酸-2-D1物理化学性质

本表包含该物质理化参数，如熔点、沸点、密度、溶解度、旋光性等理化指标，无数据项标记为N/A。

• 熔点: >300 °C(lit.)
• 分子式: C₆H₁₂DNO₂
• 分子量: 132.17900
• 精确质量: 132.10100
• PSA: 63.32000
• LogP: 1.14470
• InChIKey: ROHFNLRQFUQHCH-VXNMYXNSSA-N
• SMILES: CC(C)CC(N)C(=O)O

L-亮氨酸-2-D1英文别名

本表罗列该化合物全部英文别名、系统命名、CAS别名等英文名称集合。

• homoserine lactone*HBr
• (S)-2-[2H1]-Leu
• L-homoserine lactone hydrobromide
• (S)-2-amino-2-deuterio-4-methyl-pentanoic acid
• L-homoserine lactone HBr
• (S)-3-Aminodihydrofuran-2(3H)-one hydrobromide

L-亮氨酸-2-D1常见问题

本部分为该化合物相关常见问答，包含基础参数、性状、储存条件等高频咨询问题与对应答案。

Q: 89836-93-1的中文名称是什么？

A: 89836-93-1的中文名称为L-亮氨酸-2-D1。

Q: L-亮氨酸-2-D1的InChIKey是什么？

A: L-亮氨酸-2-D1InChIKey为ROHFNLRQFUQHCH-VXNMYXNSSA-N。

Q: L-亮氨酸-2-D1的英文名称是什么？

A: L-亮氨酸-2-D1英文名称为l-leucine-2-d1。

Q: L-亮氨酸-2-D1的极性表面积PSA是多少？

A: L-亮氨酸-2-D1极性表面积PSA为63.32000。

Q: L-亮氨酸-2-D1的CAS号是多少？

A: L-亮氨酸-2-D1CAS号为89836-93-1。

Q: L-亮氨酸-2-D1的分子量是多少？

A: L-亮氨酸-2-D1分子量为132.17900。

Q: L-亮氨酸-2-D1的SMILES表达式是什么？

A: L-亮氨酸-2-D1SMILES表达式为CC(C)CC(N)C(=O)O。

Q: L-亮氨酸-2-D1有哪些英文别名？

A: L-亮氨酸-2-D1英文别名有：homoserine lactone*HBr、 (S)-2-[2H1]-Leu、 L-homoserine lactone hydrobromide、 (S)-2-amino-2-deuterio-4-methyl-pentanoic acid、 L-homoserine lactone HBr、 (S)-3-Aminodihydrofuran-2(3H)-one hydrobromide。

Q: L-亮氨酸-2-D1有什么用途？

A: L-亮氨酸-2-D1主要用途：L-亮氨酸-d1是氘标记的L-亮氨酸。L-亮氨酸是一种必需的支链氨基酸(BCAA),可激活mTOR信号通路[1]。

Q: L-亮氨酸-2-D1的熔点是多少？

A: L-亮氨酸-2-D1熔点为>300 °C(lit.)。